Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
Blood Cancer Journal
|
November 21, 2018
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
L Sanoja-Flores, J Flores-Montero, J J Garcés, et al.
Leukemia
|
November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia
|
August 2, 2016
Differentiation stage of myeloma plasma cells: biological and clinical significance
B Paiva, N Puig, M T Cedena, et al.
Blood Cancer Journal
|
April 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression
A Medina-Herrera, I Vazquez, I Cuenca, et al.
Leukemia
|
December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myeloma
P G Richardson, M Delforge, M Beksac, et al.
Journal of Hematology & Oncology
|
April 14, 2021
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Maria V Mateos, Maria Gavriatopoulou, Thierry Facon, et al.
Leukemia
|
June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
S Giralt, E A Stadtmauer, J L Harousseau, et al.
Leukemia
|
January 21, 2017
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J Flores-Montero, L Sanoja-Flores, B Paiva, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
Blood Cancer Journal
|
November 21, 2018
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
L Sanoja-Flores, J Flores-Montero, J J Garcés, et al.
Leukemia
|
November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia
|
August 2, 2016
Differentiation stage of myeloma plasma cells: biological and clinical significance
B Paiva, N Puig, M T Cedena, et al.
Blood Cancer Journal
|
April 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression
A Medina-Herrera, I Vazquez, I Cuenca, et al.
Leukemia
|
December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myeloma
P G Richardson, M Delforge, M Beksac, et al.
Journal of Hematology & Oncology
|
April 14, 2021
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Maria V Mateos, Maria Gavriatopoulou, Thierry Facon, et al.
Leukemia
|
June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
S Giralt, E A Stadtmauer, J L Harousseau, et al.
Leukemia
|
January 21, 2017
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J Flores-Montero, L Sanoja-Flores, B Paiva, et al.
Page
of 18